Get the Stockscreener App
23.97
1.60%
-0.39
After Hours:
23.97
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $23.97, with a volume of 4.77M.
It is down -1.60% in the last 24 hours and down -7.20% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$24.36
Open:
$24.2
24h Volume:
4.77M
Relative Volume:
0.73
Market Cap:
$12.39B
Revenue:
$11.32B
Net Income/Loss:
$-981.00M
P/E Ratio:
-12.27
EPS:
-1.9532
Net Cash Flow:
$714.00M
1W Performance:
-0.13%
1M Performance:
-7.20%
6M Performance:
+44.22%
1Y Performance:
+4.67%
1-Day Range:
$23.82
$24.60
1-Week Range:
$23.23
$24.60
52-Week Range:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
23.97 | 12.08B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
414.52 | 138.47B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.16 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
225.98 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.45 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.00 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Can Execution Lift Baxter International (NYSE:BAX) From Here? - Kalkine Media
Baxter International stock: Company releases Connected Hospital Report on September 30, 2026 - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What Investors Might Be Missing On Baxter International (BAX) - Yahoo Finance
Baxter Releases Inaugural Connected Hospital Report - Business Wire
Baxter International stock faces a Q3 EPS estimate cut - AD HOC NEWS
Why Investors Need to Take Advantage of These 2 Medical Stocks Now - Zacks Investment Research
Baxter International stock trades above analyst target - AD HOC NEWS
Baxter International (BAX) Q1 2026 Earnings Call Transcript - Fortune
Baxter International (BAX) Q2 2026 Earnings Call Transcript - Fortune
Baxter International stock heads into the open after a 1.9 percent S&P 500 drop - AD HOC NEWS
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now - Eastern Progress
Baxter International stock heads into the open after a 1.2 percent drop - AD HOC NEWS
Baxter International stock holds at USD 22.93 as storm damage weighs - AD HOC NEWS
A Look at Baxter International Inc (BAX) After 3.3% Gain -- GF V - GuruFocus
Baxter International Inc (BAX) Stock Price Today: $23.74 - Pluang
How Baxter International's WNC plant rebuilt post-Helene | Video - The Asheville Citizen Times
Baxter International, McDowell County - Yahoo
Baxter plant's Helene recovery has a human face - The Asheville Citizen Times
Baxter International stock holds near its yearly high - AD HOC NEWS
Baxter International stock gains 0.57 percent ahead of the open - AD HOC NEWS
Baxter International stock gains on cautious analyst tone - AD HOC NEWS
Is Baxter Stock Underperforming the Nasdaq? - Barchart.com
Top 3 Health Care Stocks That May Rocket Higher In September - Benzinga
Baxter International Inc. (BAX) Stock Analysis: Assessing a 26% Potential Upside Amid Healthcare Sector Challenges - DirectorsTalk Interviews
Baxter International stock reacts to guidance after second-quarter 2026 results - AD HOC NEWS
Baxter International stock slips as Q2 beat and raise still matters - AD HOC NEWS
Baxter International stock steadies near recent lows as analysts stick with Hold ratings - AD HOC NEWS
Baxter International stock heads into the open after a 0.8% dip - AD HOC NEWS
Baxter International stock heads into the open after a 0.6% dip - AD HOC NEWS
Baxter International stock rises on 24.5 percent YTD gain - AD HOC NEWS
Baxter International stock heads into the open after a 24.5 percent year-to-date gain - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring The 20.7% Upside Potential - DirectorsTalk Interviews
Baxter International Inc Share PriceBAX, RNS News, Articles, Quotes, & Charts (NYSE:BAX) - Proactive financial news
Securities Lawsuit Alert: Baxter International, Inc. (BAX) – Contact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter: This Turnaround Stock Is Up and Still 38% Undervalued - morningstar.com
Baxter International stock heads into the open after a modest gain - ad-hoc-news.de
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12 - marketscreener.com
Baxter at Wells Fargo conference: growth improves as turnaround continues By Investing.com - Investing.com UK
A Look at Baxter International Inc (BAX) After 3.8% Decline -- G - GuruFocus
Baxter International stock trades sideways as technical signals flag limited near-term upside - ad-hoc-news.de
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International stock holds steady as investors await next earnings signal - ad-hoc-news.de
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - Yahoo Finance
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - ad-hoc-news.de
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):